Published in Clin Orthop Relat Res on December 18, 2009
Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report. Osteoporos Int (2010) 1.83
Bisphosphonate-associated femur fractures have high complication rates with operative fixation. Clin Orthop Relat Res (2012) 1.15
Femoral stress fractures associated with long-term bisphosphonate treatment. Clin Orthop Relat Res (2012) 1.01
Management strategy for symptomatic bisphosphonate-associated incomplete atypical femoral fractures. HSS J (2012) 0.87
Spontaneous acetabular periprosthetic fracture in a patient continuously having zoledronic acid. Clin Orthop Surg (2014) 0.86
The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future. Oncologist (2011) 0.78
Low-energy femoral shaft fractures after long-term alendronate therapy: report of seven cases. Eur J Orthop Surg Traumatol (2014) 0.78
5-Androstene-3β,7β,17β-triol (β-AET) slows thermal injury induced osteopenia in mice: relation to aging and osteoporosis. PLoS One (2010) 0.77
Applying low-intensity pulsed ultrasounds (LIPUS) to a zoledronate-associated atypical femoral shaft fracture without cessation of zoledronate therapy for 3 years follow up: a case report. Clin Cases Miner Bone Metab (2015) 0.77
Simultaneous, bilateral, complete atypical femoral fractures after long-term alendronate use. J Orthop (2016) 0.75
Association between alendronate and atypical femur fractures: a meta-analysis. Endocr Connect (2014) 0.75
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet (1996) 13.20
Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA (2006) 12.47
Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab (2004) 8.36
Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br (2007) 4.10
Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int (2008) 3.80
Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma (2008) 3.74
An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury (2008) 3.50
Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc (2008) 2.66
Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study. J Bone Miner Res (2009) 2.65
Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab (2008) 1.99
Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension. J Bone Miner Res (2004) 1.93
Effects of differences in mineralization on the mechanical properties of bone. Philos Trans R Soc Lond B Biol Sci (1984) 1.79
Case reports: two femoral insufficiency fractures after long-term alendronate therapy. Clin Orthop Relat Res (2009) 1.55
Long-term safety of bisphosphonates. J Clin Endocrinol Metab (2005) 1.50
Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra. Osteoporos Int (2007) 1.47
Bilateral fractures of the femur diaphysis in a patient with rheumatoid arthritis on long-term treatment with alendronate: clues to the mechanism of increased bone fragility. J Bone Miner Res (2009) 1.41
Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations. Am J Manag Care (2008) 1.30
Subtrochanteric displaced insufficiency fracture after long-term alendronate therapy--a case report. Acta Orthop (2008) 1.24
Subtrochanteric stress fractures in runners. Am J Sports Med (1982) 1.08
Bisphosphonates for postmenopausal osteoporosis: determining duration of treatment. Curr Osteoporos Rep (2009) 0.99
Hip pain in a case of hypophosphatemic osteomalacia. Am J Orthop (Belle Mead NJ) (2003) 0.94
A displaced subtrochanteric stress fracture in a young amenorrheic athlete. Am J Sports Med (1992) 0.93
Bisphosphonate-induced fractures: nature strikes back? Acta Orthop (2008) 0.91
[Not Available]. Z Anat Entwicklungsgesch (1948) 0.90
Bone fragility of the peripheral skeleton during fluoride therapy for osteoporosis. Clin Orthop Relat Res (1990) 0.86
[Distribution of bony restraints in the femur]. Rev Chir Orthop Reparatrice Appar Mot (1968) 0.81
Stress fractures of the lower limbs in osteoporotic patients treated with fluoride. J Bone Miner Res (1990) 0.78
Progressive osteoblastic bone metastases in breast cancer negative on FDG-PET. Clin Nucl Med (2009) 1.00
Extra-skeletal Ewing's sarcoma in adults: presentation of two cases. Acta Orthop Belg (2010) 0.75